Cargando…

Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe

Zimbabwe has made large strides in addressing HIV. To ensure a continued robust response, a clear understanding of costs associated with its HIV program is critical. We conducted a cross-sectional evaluation in 2017 to estimate the annual average patient cost for accessing Prevention of Mother-To-Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Chingombe, Innocent, Mapingure, Munyaradzi P., Balachandra, Shirish, Chipango, Tendayi N., Gambanga, Fiona, Mushavi, Angela, Apollo, Tsitsi, Suraratdecha, Chutima, Rogers, John H., Ruangtragool, Leala, Gonese, Elizabeth, Musuka, Godfrey N., Mugurungi, Owen M., Harris, Tiffany G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372940/
https://www.ncbi.nlm.nih.gov/pubmed/34407129
http://dx.doi.org/10.1371/journal.pone.0256291
_version_ 1783739859360284672
author Chingombe, Innocent
Mapingure, Munyaradzi P.
Balachandra, Shirish
Chipango, Tendayi N.
Gambanga, Fiona
Mushavi, Angela
Apollo, Tsitsi
Suraratdecha, Chutima
Rogers, John H.
Ruangtragool, Leala
Gonese, Elizabeth
Musuka, Godfrey N.
Mugurungi, Owen M.
Harris, Tiffany G.
author_facet Chingombe, Innocent
Mapingure, Munyaradzi P.
Balachandra, Shirish
Chipango, Tendayi N.
Gambanga, Fiona
Mushavi, Angela
Apollo, Tsitsi
Suraratdecha, Chutima
Rogers, John H.
Ruangtragool, Leala
Gonese, Elizabeth
Musuka, Godfrey N.
Mugurungi, Owen M.
Harris, Tiffany G.
author_sort Chingombe, Innocent
collection PubMed
description Zimbabwe has made large strides in addressing HIV. To ensure a continued robust response, a clear understanding of costs associated with its HIV program is critical. We conducted a cross-sectional evaluation in 2017 to estimate the annual average patient cost for accessing Prevention of Mother-To-Child Transmission (PMTCT) services (through antenatal care) and Antiretroviral Treatment (ART) services in Zimbabwe. Twenty sites representing different types of public health facilities in Zimbabwe were included. Data on patient costs were collected through in-person interviews with 414 ART and 424 PMTCT adult patients and through telephone interviews with 38 ART and 47 PMTCT adult patients who had missed their last appointment. The mean and median annual patient costs were examined overall and by service type for all participants and for those who paid any cost. Potential patient costs related to time lost were calculated by multiplying the total time to access services (travel time, waiting time, and clinic visit duration) by potential earnings (US$75 per month assuming 8 hours per day and 5 days per week). Mean annual patient costs for accessing services for the participants was US$20.00 [standard deviation (SD) = US$80.42, median = US$6.00, range = US$0.00–US$12,18.00] for PMTCT and US$18.73 (SD = US$58.54, median = US$8.00, range = US$0.00–US$ 908.00) for ART patients. The mean annual direct medical costs for PMTCT and ART were US$9.78 (SD = US$78.58, median = US$0.00, range = US$0.00–US$ 90) and US$7.49 (SD = US$60.00, median = US$0.00) while mean annual direct non-medical cost for US$10.23 (SD = US$17.35, median = US$4.00) and US$11.23 (SD = US$25.22, median = US$6.00, range = US$0.00–US$ 360.00). The PMTCT and ART costs per visit based on time lost were US$3.53 (US$1.13 to US$8.69) and US$3.43 (US$1.14 to US$8.53), respectively. The mean annual patient costs per person for PMTCT and ART in this evaluation will impact household income since PMTCT and ART services in Zimbabwe are supposed to be free.
format Online
Article
Text
id pubmed-8372940
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83729402021-08-19 Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe Chingombe, Innocent Mapingure, Munyaradzi P. Balachandra, Shirish Chipango, Tendayi N. Gambanga, Fiona Mushavi, Angela Apollo, Tsitsi Suraratdecha, Chutima Rogers, John H. Ruangtragool, Leala Gonese, Elizabeth Musuka, Godfrey N. Mugurungi, Owen M. Harris, Tiffany G. PLoS One Research Article Zimbabwe has made large strides in addressing HIV. To ensure a continued robust response, a clear understanding of costs associated with its HIV program is critical. We conducted a cross-sectional evaluation in 2017 to estimate the annual average patient cost for accessing Prevention of Mother-To-Child Transmission (PMTCT) services (through antenatal care) and Antiretroviral Treatment (ART) services in Zimbabwe. Twenty sites representing different types of public health facilities in Zimbabwe were included. Data on patient costs were collected through in-person interviews with 414 ART and 424 PMTCT adult patients and through telephone interviews with 38 ART and 47 PMTCT adult patients who had missed their last appointment. The mean and median annual patient costs were examined overall and by service type for all participants and for those who paid any cost. Potential patient costs related to time lost were calculated by multiplying the total time to access services (travel time, waiting time, and clinic visit duration) by potential earnings (US$75 per month assuming 8 hours per day and 5 days per week). Mean annual patient costs for accessing services for the participants was US$20.00 [standard deviation (SD) = US$80.42, median = US$6.00, range = US$0.00–US$12,18.00] for PMTCT and US$18.73 (SD = US$58.54, median = US$8.00, range = US$0.00–US$ 908.00) for ART patients. The mean annual direct medical costs for PMTCT and ART were US$9.78 (SD = US$78.58, median = US$0.00, range = US$0.00–US$ 90) and US$7.49 (SD = US$60.00, median = US$0.00) while mean annual direct non-medical cost for US$10.23 (SD = US$17.35, median = US$4.00) and US$11.23 (SD = US$25.22, median = US$6.00, range = US$0.00–US$ 360.00). The PMTCT and ART costs per visit based on time lost were US$3.53 (US$1.13 to US$8.69) and US$3.43 (US$1.14 to US$8.53), respectively. The mean annual patient costs per person for PMTCT and ART in this evaluation will impact household income since PMTCT and ART services in Zimbabwe are supposed to be free. Public Library of Science 2021-08-18 /pmc/articles/PMC8372940/ /pubmed/34407129 http://dx.doi.org/10.1371/journal.pone.0256291 Text en https://creativecommons.org/publicdomain/zero/1.0/This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Chingombe, Innocent
Mapingure, Munyaradzi P.
Balachandra, Shirish
Chipango, Tendayi N.
Gambanga, Fiona
Mushavi, Angela
Apollo, Tsitsi
Suraratdecha, Chutima
Rogers, John H.
Ruangtragool, Leala
Gonese, Elizabeth
Musuka, Godfrey N.
Mugurungi, Owen M.
Harris, Tiffany G.
Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe
title Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe
title_full Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe
title_fullStr Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe
title_full_unstemmed Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe
title_short Patient costs for prevention of mother-to-child HIV transmission and antiretroviral therapy services in public health facilities in Zimbabwe
title_sort patient costs for prevention of mother-to-child hiv transmission and antiretroviral therapy services in public health facilities in zimbabwe
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372940/
https://www.ncbi.nlm.nih.gov/pubmed/34407129
http://dx.doi.org/10.1371/journal.pone.0256291
work_keys_str_mv AT chingombeinnocent patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT mapinguremunyaradzip patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT balachandrashirish patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT chipangotendayin patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT gambangafiona patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT mushaviangela patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT apollotsitsi patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT suraratdechachutima patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT rogersjohnh patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT ruangtragoolleala patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT goneseelizabeth patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT musukagodfreyn patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT mugurungiowenm patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe
AT harristiffanyg patientcostsforpreventionofmothertochildhivtransmissionandantiretroviraltherapyservicesinpublichealthfacilitiesinzimbabwe